David Cleevely
Angel Investor
Cambridge, United Kingdom
David Cleevely (FREng, FIET) is an entrepreneur and international telecoms expert who has built and advised many companies, principally in Cambridge, UK.He has invested in over 35 companies (including Neul). David was founder and former Chairman of telecoms consultancy Analysys (acquired by Datatec International in 2004). In 1998, he co-foundedthe web based antibody company Abcam (ABC.L) with Jonathan Milner and was Chairman until November 2009. In late 2004 he co-founded the 3G femto base station company, 3WayNetworks, which was sold to Airvana in April 2007. He has been a prime mover behind Cambridge Network, co-founder of Cambridge Wireless, co-founder and Chairman of Cambridge Angels and is a member of the IET Communications Policy Panel. For 8 years until March 2009 he was a member of the Ofcom Spectrum Advisory Board. From 2001 to 2008 David was a member of the Ministry of Defence Board overseeing information systems and services (DES-ISS, formerly the Defence Communications Services Agency).
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries David Cleevely invests in
Stages David Cleevely invests in
Countries David Cleevely invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 5 (71%)
- Biotechnology 2 (29%)
- SaaS 1 (14%)
- Travel 1 (14%)
- Privacy 1 (14%)
Stage
- Seed 2 (29%)
- Pre-Seed 2 (29%)
- Angel 1 (14%)
- Series A 1 (14%)
- Series C 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Sanome are combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease. The IVD innovation engine, will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people. | $2.5M / Pre-Seed / Sep 28, 2021 | ||
| Connect4 provides a client meeting app. It is designed to help client-centric teams deliver smarter client meetings. First-class client meetings lead to strong relationships and healthy recurring business. They built around the concept of pods, which are central workspaces for teams and clients. | Pre-Seed / Jul 31, 2021 | ||
| Migacore Technologies is an early stage data science startup that focuses on bringing predictive demand forecasting for airlines. | Seed / Feb 28, 2018 | ||
| Focal Point consists of a team of experts with more than 30 years of combined knowledge in the world of positioning, navigation and timing. The company has revolutionised navigation and positioning software through the development of two core products: S-GNSS and D-Tail. S-GNSS drastically improves the sensitivity and accuracy of GPS receivers,making it far easier to track people indoors and in remote environments. D-Tail taps into sensors already within a smartphone or wearable device to more accurately track users in three-dimensions, producing data that can be trusted more than ever before. Founder Dr Ramsey Faragher is a world-leading expert in GNSS-denied positioning and has previously worked as a senior research associate at the University of Cambridge and a principal scientist at the BAE Systems Advanced Technology Centre, where he developed award-winning technologies. His early work included developing a range of multi-sensor positioning systems for unmanned aerial and ground vehicles and the Astute nuclear submarine. He was also part of the original design team for the ExoMars martian rover's "Seeker" visual navigation system. | $641.8K / Seed / Sep 17, 2015 | ||
| Privitar is an enterprise software company with a global client-base across North America, Europe, and Asia. The company is the development and adoption of privacy engineering technology enabling its customers to innovate and leverage data with an uncompromising approach to data privacy. Its software is designed to allow clients to analyzepotentially sensitive data while respecting customers’ privacy and confidentiality, resulting in the ability to leverage large, sensitive data sets while ensuring compliance with regulations (such as GDPR, CPRA and HIPAA) and ethical data principles.Privitar was founded in 2014 and is based in London, UK. | $1.2M / Angel / Jul 17, 2015 | ||
| Cambridge Communication Systems Ltd (CCS), a Cambridge, UK-based newly formed technology company that intends to provide a cost-effective backhaul solution for the mobile infrastructure. | $5.7M / Series A / Mar 24, 2013 | ||
| Horizon Discovery Group PLC is a UK life science company that uses gene editing and gene modulation platforms to produce cells, applying them in research and clinical applications that advance human health. The Company’s gene editing and gene modulation platform, are able to alter almost any DNA sequence or RNA transcription, has generated acatalogue of over 1,000,000 cell and reagent products that help researchers recapitulate the genetic and protein anomalies found in diseases like cancer. These models have been adopted by c12, 000 organizations to better understand of the predictors and drivers of disease and drug response, and by Horizon in a range of services offered to customers, as well as in the Company’s own research R&D pipeline. | $14.4M / Series C / Sep 13, 2011 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does David Cleevely invest in?
David Cleevely invests primarily in Software, Biotechnology and SaaS startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact David Cleevely?
Public channels for David Cleevely include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did David Cleevely last invest?
The most recent investment recorded for David Cleevely closed in Sep 2021. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
